stella
beta
A Phase 1/2 Study to Evaluate the Safety, PK and Efficacy of TNP-2092 Administered Via IA Injection in PJI Participants — Stella
Recruiting
Back to Periprosthetic Joint Infection (PJI) trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
China
The First Affiliated Hospital of Xinjiang Medical University, Ürümqi, Xinjiang
View full record on ClinicalTrials.gov